object
studi
aim
determin
whether
mycobacterium
bovi
bacillu
bcg
treatment
revers
establish
allerg
airway
inflamm
balbc
mous
model
ovalbumin
ova
induc
airway
inflamm
method
ova
sensit
balbc
mice
challeng
aerosol
ova
day
mice
intranas
treat
bcg
day
twentyfour
hour
last
challeng
blood
sampl
collect
detect
antiova
immunoglobulin
isotyp
bronchoalveolar
lavag
bal
harvest
cell
count
addit
lung
collect
histolog
analysi
detect
eosinophil
peroxidas
epo
activ
measur
cytokin
express
also
determin
lung
tissu
flow
cytometri
result
bcg
treatment
abl
inhibit
establish
allerg
decreas
allergeninduc
eosinophil
inflamm
epo
activ
level
serum
level
ige
mycobacteria
treatment
increas
lung
level
express
cell
addit
increas
product
cell
observ
even
though
detect
chang
notic
conclus
bcg
treatment
inhibit
featur
allerg
airway
inflamm
result
suggest
mechan
underli
downregulatori
effect
bcg
ovainduc
airway
inflamm
appear
associ
induct
regulatori
immun
respons
atop
asthma
chronic
respiratori
diseas
character
airway
hyperrespons
revers
airway
obstruct
lung
inflamm
high
level
allergenspecif
ige
helper
cell
thought
play
pivot
role
develop
allerg
respons
cytokin
secret
chemokin
includ
play
import
role
inflammatori
cell
recruit
mediat
contribut
clinic
featur
allerg
pathogenes
trigger
ige
product
eosinophil
inflamm
mucu
hypersecret
bronchial
hyperreact
increas
preval
allerg
diseas
asthma
particularli
industri
countri
led
hygien
hypothesi
state
newborn
infant
immun
system
skew
toward
respons
need
time
appropri
environment
stimulu
creat
balanc
immun
respons
support
hypothesi
epidemiolog
experiment
evid
shown
invers
correl
microbi
infect
allerg
diseas
similarli
anim
studi
demonstr
exposur
mycobacterium
tuberculosi
environment
mycobacteria
abl
protect
develop
allerg
respons
introduc
concept
administr
mycobacteria
product
may
therefor
use
vaccin
aim
inhibit
respons
howev
exact
mechan
underli
inhibit
still
remain
poorli
understood
induct
cytokin
suggest
caus
shift
immun
respons
thu
subsequ
prevent
inflammatori
allerg
immun
respons
nevertheless
result
indic
immunolog
mechan
behind
inhibit
much
complex
predict
addit
immunolog
regulatori
mechan
may
play
much
promin
role
context
clinic
experiment
studi
also
highlight
import
role
regulatori
cell
treg
control
allerg
diseas
provid
evid
work
manner
part
depend
addit
well
establish
transcript
factor
well
cytotox
tlymphocyt
antigen
key
role
function
treg
cell
would
crucial
modul
allergeninduc
inflamm
furthermor
demonstr
treatment
newborn
mice
mycobacterium
bovisbcg
mycobacterium
vacca
ovalbuminsensit
effect
reduc
allergen
inducedairway
eosinophilia
give
rise
treg
cell
hand
studi
fail
show
effect
suppress
allerg
featur
allergen
challeng
suggest
therapeut
efficaci
bcg
treatment
mous
model
allergi
remain
controversi
present
studi
aim
evalu
abil
bcg
suppress
establish
allerg
respons
balbc
mous
model
ovainduc
airway
inflamm
achiev
new
insight
mechan
mycobacteria
exert
antiinflammatori
effect
femal
balbc
mice
week
old
obtain
universidad
feder
de
juiz
de
fora
ufjf
anim
care
facil
hous
microisol
cage
receiv
chow
water
ad
libitum
anim
group
accord
treatment
follow
pb
sensit
airway
challeng
phosphatebuff
salin
b
bcg
sensit
airway
challeng
pb
plu
bcg
treatment
c
ova
sensit
airway
challeng
ova
ovabcg
sensit
airway
challeng
ova
plu
bcg
treatment
anim
experiment
accord
principl
brazilian
code
use
laboratori
anim
approv
ufjf
ethic
committe
use
laboratori
anim
ceeaufjf
mice
sensit
intraperiton
ip
day
ova
grade
v
sigmaaldrich
corp
usa
mg
alum
sigmaaldrich
corp
usa
anim
challeng
min
aerosol
ova
pb
inalatec
plu
nevoni
brazil
day
mice
twice
intranas
treat
day
cfuml
mycobacterium
bovi
bacillu
moreau
substrain
ataupho
de
paiva
foundat
rio
de
janeiro
brazil
pb
fig
twentyfour
hour
last
ova
challeng
mice
anesthet
ip
solut
ketamin
mgkg
syntec
brazil
xylazin
mgkg
calmiun
agen
brazil
exsanguin
via
brachial
plexu
blood
sampl
centrifug
x
g
min
centrifug
eppendorf
germani
serum
separ
store
subsequ
bronchoalveolar
lavag
bal
perform
intratrach
instil
ml
pb
three
time
cell
pellet
resuspend
ml
pb
contain
fetal
bovin
serum
chest
caviti
open
remov
lung
lobe
total
leukocyt
count
determin
percentag
differenti
count
leukocyt
bal
determin
use
standard
morpholog
criteria
examin
cytospin
slide
fanem
brazil
panopt
stain
laborclin
ltda
pinhai
brazil
determin
eosinophil
peroxidas
epo
activ
mg
lung
tissu
homogen
ml
pb
centrifug
x
g
jouan
thermo
electron
corpor
usa
min
pellet
suspend
ml
htab
pb
sampl
frozen
three
time
liquid
nitrogen
centrifug
x
g
min
thermo
electron
usa
supernat
use
enzymat
assay
briefli
ml
ophenyldiamin
opd
solut
ad
ml
tri
buffer
follow
addit
h
use
plate
substrat
solut
ad
sampl
min
reaction
stop
h
absorb
measur
nm
micropl
reader
spectramax
molecular
devic
usa
order
evalu
level
cytokin
chemokin
lung
tissu
mg
tissu
homogen
ml
pb
contain
proteas
inhibitor
mm
phenylmethylsulphonyl
fluorid
mm
benzethonium
chlorid
mm
edta
aprotinin
tween
sampl
centrifug
min
x
g
thermo
electron
usa
level
cytokin
chemokin
supernat
measur
use
commerci
avail
elisa
kit
opteia
bd
bioscienc
cytokin
r
diagnost
chemokin
accord
manufactur
instruct
quantif
antiovaspecif
ige
antibodi
determin
elisa
briefli
plate
sensit
ovalbumin
incub
h
plate
wash
tween
pbst
block
fetal
bovin
serumpbst
h
room
temperatur
plate
wash
pbst
serum
ige
dilut
ad
per
well
incub
h
plate
wash
biotinconjug
rat
antimous
ige
pharmingen
bd
bioscienc
ad
h
incub
room
temperatur
substrat
solut
contain
citric
acid
sodium
phosphat
distil
water
opd
hydrogen
peroxid
ad
reaction
stop
h
optic
densiti
measur
nm
micropl
reader
spectramax
molecular
devic
lung
remov
mash
cell
strainer
red
blood
cell
lyse
ack
buffer
cell
suspens
wash
twice
rpmi
adjust
cell
per
well
cell
stain
florescenceconjug
antibodi
cell
surfac
marker
includ
bd
biosciencepharmingen
express
measur
cell
collect
stain
cell
surfac
marker
without
stimul
describ
manufactur
instruct
surfac
marker
stain
cell
permeabil
stain
alexa
fluor
bd
biosciencepharmingen
data
acquisit
perform
use
facscalibur
becton
dickinson
san
jose
ca
data
analysi
perform
use
fc
express
softwar
de
novo
right
upper
lung
lobe
anim
fix
buffer
formalin
sampl
submit
routin
histolog
process
tissu
section
stain
hematoxylin
eosin
period
acidschiff
pa
examin
blind
fashion
optic
microscop
zeiss
hallbergmoo
germani
x
x
x
magnif
peribronchiolar
area
score
scale
inflamm
inflammatori
cell
layer
inflammatori
cell
around
structur
evalu
ring
inflammatori
cell
contain
layer
focal
inflammatori
cell
cluster
around
structur
intens
inflammatori
infiltr
pasposit
goblet
cell
quantifi
per
pa
stain
lung
statist
analysi
perform
use
graph
pad
prism
softwar
graphpad
softwar
san
diego
ca
numer
data
analyz
normal
test
kolmogorovsmirnov
subsequ
unpair
test
use
parametr
data
mann
whitney
test
nonparametr
data
signific
level
accept
test
p
data
express
mean
standard
error
order
address
whether
intranas
bcg
treatment
abl
reduc
airway
inflamm
number
total
cell
eosinophil
neutrophil
lymphocyt
macrophag
count
bal
epo
activ
level
analyz
lung
indirect
measur
eosinophil
infiltr
organ
bcg
treatment
significantli
reduc
infiltr
total
cell
bal
fig
well
eosinophil
inflamm
fig
compar
ova
group
howev
count
neutrophil
chang
ova
ovabcg
group
number
fig
b
c
e
regard
epo
bcgtreat
allerg
mice
show
decreas
epo
activ
level
compar
ova
group
fig
g
lung
section
inspect
overal
semiquantit
score
inflamm
mucu
product
ovalbumin
sensit
subsequ
airway
challeng
result
intens
peribronchi
perivascular
inflammatori
infiltr
mean
score
assign
ova
group
compar
ova
group
bcgtreat
allerg
mice
show
reduc
inflammatori
cell
infiltr
fig
c
mucu
product
fig
confirm
morphometri
analysi
mucu
cell
count
fig
bcg
treatment
effect
lung
tissu
nonallerg
mice
mean
score
less
assign
grooup
serum
level
ovaspecif
ige
measur
elisa
significantli
higher
antiova
ige
level
observ
ova
group
compar
pb
group
bcg
group
indic
allerg
immun
anim
bovi
bcg
treatment
allerg
mice
significantli
downregul
antiova
ige
serum
level
fig
b
addit
ovaspecif
level
bcgtreat
allerg
group
higher
observ
ova
group
fig
determin
manner
bcg
treatment
could
influenc
cytokin
secret
inflammatori
site
elisa
conduct
bcg
treatment
allerg
mice
result
signific
reduct
level
fig
c
also
compar
ova
group
bcgtreat
allerg
group
exhibit
signific
increas
level
fig
e
f
consist
find
bcg
group
show
increas
level
although
cytokin
level
alter
addit
bcgtreat
allerg
mice
slightli
reduc
level
compar
ova
group
fig
order
determin
role
regulatori
cell
bcginduc
inhibitori
effect
express
cell
evalu
lung
allerg
mice
bcgtreat
mice
significantli
larger
number
cell
express
compar
ova
group
fig
addit
increas
number
cell
also
observ
bcgtreat
allerg
mice
fig
consist
result
bcg
group
show
increas
express
cell
compar
pb
group
fig
b
investig
whether
reduc
allergeninduc
airway
inflamm
observ
bcgtreat
allerg
mice
associ
regulatori
cell
intracellular
product
cytokin
lung
cell
analyz
intriguingli
although
bcg
administr
allerg
mice
alter
number
cell
significantli
greater
number
cell
observ
fig
interestingli
bcg
treatment
nonallerg
mice
abl
induc
significantli
express
cell
recent
increas
preval
allerg
disord
particularli
industri
countri
provid
support
addit
role
environment
factor
pathogenesi
immun
hypersensit
inde
epidemiolog
evid
suggest
invers
correl
immun
respons
viral
bacteri
infect
develop
preval
allerg
diseas
context
mani
experiment
studi
show
mycobacterium
bovisbacil
bcg
mycobacteria
effect
prevent
allerg
asthmat
respons
probabl
regulatori
tcell
immun
respons
howev
therapeut
efficaci
bcg
treatment
allerg
airway
inflamm
allergen
challeng
remain
poorli
understood
controversi
current
studi
effect
give
bcg
mice
previou
exposur
allergen
evalu
result
show
mycobacteria
treatment
abl
inhibit
ovainduc
airway
inflamm
reduc
mainli
pathogen
allerg
featur
airway
eosinophil
inflamm
ige
product
b
cell
type
cytokin
product
mucu
hypersecret
reduct
airway
pathogenesi
allergen
associ
switch
immun
respons
toward
regulatori
immun
respons
interestingli
intranas
bcg
administr
recruit
cell
express
lung
accompani
increas
cell
protect
properti
bcg
vaccin
thought
lie
mainli
abil
induc
effector
cell
respons
secret
cytokin
includ
way
bcgdriven
product
propos
shift
allergenspecif
respons
phenotyp
subsequ
inhibit
airway
inflammatori
immun
respons
keep
preview
studi
present
result
demonstr
improv
airway
inflamm
correl
increas
product
associ
suppress
well
relev
ige
shift
toward
protect
isotyp
product
altogeth
result
suggest
allergi
model
import
role
master
regul
immun
respons
sinc
well
establish
cytokin
exert
direct
inhibitori
effect
well
induc
instead
ige
product
b
cell
hand
studi
demonstr
treatment
mycobacteria
confer
protect
allergen
lung
inflamm
mechan
independ
probabl
observ
appar
discrep
due
differ
studi
design
particularli
regard
tempor
relationship
mycobacteria
treatment
allergen
exposur
besid
induc
effect
extens
shown
mycobacteria
treatment
still
abl
increas
product
would
anoth
mechan
bcg
suppress
inflammatori
process
mous
model
allergi
context
demonstr
heatkil
vacca
treatment
improv
pulmonari
inflamm
without
induc
respons
instead
protect
effect
associ
induct
low
treg
cell
secret
upon
transfer
could
protect
recipi
allerg
mice
airway
inflamm
line
find
increas
level
found
present
studi
support
idea
treg
cell
involv
bcginduc
inhibitori
effect
therefor
aim
confirm
whether
bcgmodul
effect
associ
induc
treg
cell
express
cell
investig
flow
cytometri
analysi
demonstr
express
upregul
allerg
bcgtreat
mice
suggest
cellcel
contact
inhibit
may
involv
regulatori
mechan
addit
action
result
similar
earlier
studi
although
author
studi
evalu
prevent
effect
neonat
bcg
vaccin
inhibit
allerg
eosinophil
inflamm
induc
mice
present
studi
assess
abil
bcg
amelior
establish
allerg
respons
high
respond
balbc
mice
respect
find
encourag
modul
establish
allerg
tcell
respons
challeng
difficult
modul
primari
respons
addicion
import
find
current
studi
product
cell
chang
allerg
mice
bcg
treatment
suggest
immun
cell
subset
may
involv
bcginduc
regul
given
key
role
dendrit
cell
dc
drive
maintain
immun
respons
inhal
allergen
may
possibl
mycobacteria
interfer
dcdriven
sensit
inde
recent
demonstr
dc
subset
bcginfect
mice
produc
respect
bcgmodul
effect
mediat
immun
deviat
regul
data
suggest
dc
import
coordin
differ
bcginduc
allergi
inhibit
rais
possibl
dc
might
also
promin
sourc
detect
present
work
therefor
studi
aim
evalu
effect
intranas
bcg
treatment
dc
activ
would
help
understand
mechan
mycobacteria
inhibit
allerg
inflamm
final
sinc
recent
report
shown
lymphocyt
may
play
import
regulatori
activ
involv
cell
investig
surprisingli
analysi
reveal
cell
allerg
mice
product
increas
bcg
administr
suggest
cell
could
import
dampen
allergeninduc
lung
inflamm
last
year
studi
carri
shed
light
role
cell
induct
regul
inflammatori
respons
recent
demonstr
cellderiv
diminish
diseas
sever
mice
coronavirusinduc
acut
enceph
parallel
studi
shown
transfer
activ
cell
sensit
mice
reduc
product
allergenspecif
ige
develop
airway
hyperact
regulatori
cell
could
exert
inhibitori
effect
directli
kill
immun
cell
indirectli
secret
accord
find
preview
research
provid
evid
system
immun
allergen
induc
regulatori
cell
abl
inhibit
develop
allerg
diarrhea
mechan
involv
express
spite
exist
correl
contribut
cell
develop
allerg
airway
inflamm
remain
inconclus
demonstr
deplet
cell
earli
stage
sensit
prevent
develop
eosinophil
airway
infiltr
allergeninduc
airway
hyperreact
system
sensit
establish
cell
may
play
bystand
proinflammatori
role
develop
allerg
airway
diseas
sinc
exhibit
high
capac
produc
cytokin
even
though
high
amount
detect
therefor
studi
respect
help
comprehens
elucid
role
cell
subset
allerg
airway
pathogenes
particularli
relationship
bcg
modul
effect
induct
regulatori
cell
conclus
studi
demonstr
intranas
bcg
treatment
capabl
enhanc
establish
allergendriven
inflammatori
respons
markedli
hinder
develop
downstream
effector
phase
allergi
result
show
evid
coexist
immun
deviat
regulatori
mechan
modul
effect
inflamm
bcg
increas
product
associ
higher
express
seem
decis
inhibitori
effect
moreov
mycobacteria
treatment
induc
product
cell
suggest
particip
import
regul
mechan
addit
regulatori
cell
although
therapeut
role
bcg
compat
current
version
hygien
hypothesi
analysi
hypothesi
progress
exact
mechan
bcg
exert
effect
remain
open
therefor
studi
carri
elucid
whether
possibl
use
mycobacteria
select
induc
allergenspecif
regulatori
cell
furthermor
new
insight
mechan
action
bcg
treatment
help
understand
abnorm
immun
respons
result
allerg
diseas
